Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke

Publisher： Karger

E-ISSN： 1421-9913|74|3-4|127-134

ISSN： 0014-3022

Source： European Neurology, Vol.74, Iss.3-4, 2015-09, pp. : 127-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study

By  

Cerebrovascular Diseases, Vol. 42, Iss. 1-2, 2016-03 ,pp. : 41-48

Karger

Access to resources Recommend Favorite

Effects of Uric Acid Levels on Outcome in Severe Ischemic Stroke Patients Treated with Intravenous Recombinant Tissue Plasminogen Activator

By  

European Neurology, Vol. 71, Iss. 3-4, 2013-12 ,pp. : 132-139

Karger

Access to resources Recommend Favorite

Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 22, Iss. 5-6, 2006-11 ,pp. : 423-428

Karger

Access to resources Recommend Favorite

Early Neurological Deterioration following Intravenous Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Lacunar Stroke

By  

Cerebrovascular Diseases, Vol. 26, Iss. 4, 2008-08 ,pp. : 355-359

Karger

Access to resources Recommend Favorite

Centenarian Stroke Treated with Tissue-Type Plasminogen Activator

By  

Cerebrovascular Diseases, Vol. 13, Iss. 4, 2002-05 ,pp. : 285-287

Karger

Access to resources Recommend Favorite